This insider cluster is routine and carries no actionable signal. The aggregate dollar amount is trivial for a $52B company, and no C-suite insider participated. The derivative exercises and same-day sells by Chopra suggest tax/option-exercise planning rather than a bearish view. No trade recommendation warranted, ignore for trading purposes.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 1 $90.74entry
- T+1 · 3mo ago +0.09%α −0.36% · $90.82
- T+5 · 2mo ago −5.03%α −5.11% · $86.18
- T+20 · 7w ago −4.87%α −5.19% · $86.32
- T+53 · todayOpen
- T+60 · in 8d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of four Edwards Lifesciences insiders sold a total of $507K in open-market sales over a 7-day window. All sales are by mid-level executives (SVPs and CVPs). The total dollar amount represents ~0.001% of the $52B market cap, which is trivial and routine. The cluster is entirely sells, no buys, and the aggregate value is immaterial relative to company size, this is likely liquidity-driven or tax-related selling, not a bearish signal.
Key Financial Metrics
Key Facts
- 4 insiders sold shares in open-market transactions totaling $507,000
- Sell transactions are 100% of the cluster; no open-market buys
- Total value equals ~0.001% of EW's $52B market cap (proportionality: trivial)
- All sellers are mid-level executives (CVP, SVP); no C-suite (CEO/CFO) involvement
- Daveen Chopra also exercised 31,800 shares via derivative (non-cash $0 transaction) and immediately sold them, typical broker-driven exercise-and-sell pattern
Financial Impact
Total insider sales of $507K against a $52B market cap, represents ~0.001% of market value, negligible economic impact
Risk Factors
- No material risk identified from this insider activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EW-1788213700911 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Viewing Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers